Literature DB >> 24992637

Triterpene lactones from cultures of Ganoderma sp. KM01.

Waranya Lakornwong1, Kwanjai Kanokmedhakul, Somdej Kanokmedhakul, Palangpon Kongsaeree, Samran Prabpai, Phoutthasone Sibounnavong, Kasem Soytong.   

Abstract

A revised structure of colossolactone G (1), seven new triterpene lactones, ganodermalactones A-G (2-8), and five known triterpene lactones, colossolactone I (9), schisanlactone B (10), colossolactone B (11), colossolactone E (12), and colossolactone IV (13), and ergosterol have been isolated from cultured biomass of the macrofungi Ganoderma sp. KM01. Their structures were identified by spectroscopic methods. Structures and relative configurations of 3, 7, and 8 were confirmed by X-ray crystallographic analysis. Compounds 7, 10, and 12 exhibited antimalarial activity against Plasmodium falciparum in the range 6.0-10.0 μM (IC50).

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24992637     DOI: 10.1021/np400846k

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  4 in total

1.  Two Furanosesterterpenoids from the Sponge Luffariella variabilis.

Authors:  Peni Ahmadi; Masahiro Higashi; Nicole J de Voogd; Junichi Tanaka
Journal:  Mar Drugs       Date:  2017-08-10       Impact factor: 5.118

Review 2.  Current and future perspective on antimicrobial and anti-parasitic activities of Ganoderma sp.: an update.

Authors:  Buddha Bahadur Basnet; Li Liu; Li Bao; Hongwei Liu
Journal:  Mycology       Date:  2017-05-24

3.  Xuetonglactones A-F: Highly Oxidized Lanostane and Cycloartane Triterpenoids From Kadsura heteroclita Roxb. Craib.

Authors:  Nuzhat Shehla; Bin Li; Liang Cao; Jianping Zhao; Yuqing Jian; Muhammad Daniyal; Atia-Tul Wahab; Ikhlas A Khan; Duan-Fang Liao; Atta-Ur Rahman; M Iqbal Choudhary; Wei Wang
Journal:  Front Chem       Date:  2020-01-21       Impact factor: 5.221

Review 4.  Ganoderma lucidum: Unutilized natural medicine and promising future solution to emerging diseases in Africa.

Authors:  M A Oke; F J Afolabi; O O Oyeleke; T A Kilani; A R Adeosun; A A Olanbiwoninu; E A Adebayo
Journal:  Front Pharmacol       Date:  2022-08-22       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.